F. Adam Abulawi

Mr. Abulawi’s representative matters include advising:

• Gurnet Point Capital in its take-private acquisition of Radius Health, Inc., a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health, neurology orphan diseases, and oncology, in a transaction valued at approximately US$890 million
• Searchlight Capital Partners in its take-private acquisition of Hemisphere Media Group, a leading US media company targeting the US Hispanic and Latin American markets
• ArcLight Capital Partners in its acquisition of a solar power platform in Puerto Rico from Sonnedix, the global solar independent power producer
• Partner’s Group in its US$2.2 billion acquisition of DiversiTech, the largest manufacturer of parts and accessories for heating, ventilation, and air condition equipment in the US
• Syneos Health (NASDAQ), a fully integrated biopharmaceutical solutions organization, in its acquisition of RxDataScience, a leading healthcare-focused data analytics, data management, and artificial intelligence company
• The New Home Company (NYSE), a new generation homebuilder, in its US$173 million sale to funds managed by Apollo Global Management
• The Board Committee of Viacom (NASDAQ) in its US$30 billion merger with CBS*
• Hasbro (NASDAQ), a global play and entertainment company, in its US$3.8 billion acquisition of Entertainment One*
• J.D. Power, a provider of analytics and market research, in its US$1.8 billion sale to Thoma Bravo*
• Janssen Biotech, a Janssen Pharmaceutical Company of Johnson & Johnson (NYSE), in its US$750 million acquisition of all rights to the investigational compound bermekimab from XBiotech*

*Matter handled prior to joining Latham